We are live on
!
Find out more
MPU
MVM Partners (UK) Portfolio holdings
AUM
$149M
1-Year Est. Return
6.81%
This Fund
S&P 500
This Quarter
Est. Return
+12.29%
1 Year Est. Return
+6.81%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$149M
AUM Growth
-$134M
(-47%)
Cap. Flow
-$167M
Cap. Flow
% of AUM
-111.52%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
1
Closed
2
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FNA
Paragon 28, Inc.
FNA
|
+$113M |
| 2 |
OPTN
OptiNose
OPTN
|
+$45.5M |
| 3 |
MDxHealth
MDXH
|
+$7.56M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
SFI
JAMH
SC
AEPBI
HGM
EVC
SP
HCM
MVM Partners (UK)'s Q3 2022 Portfolio in Review
As of Q3 2022, MVM Partners (UK) held 3 positions worth $149M, down 47% from $283M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
MVM Partners (UK) withdrew a net $167M in Q3 2022, closing 2 positions and reducing 1 holding. Its most notable exit was OptiNose, an estimated $45.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- MVM Partners (UK)'s biggest Q3 2022 reduction was Paragon 28, Inc., cutting an estimated $113M.
- MVM Partners (UK) fully exited OptiNose in Q3 2022, selling an estimated $45.5M.
- MVM Partners (UK)'s ten largest holdings make up 100% of its $149M portfolio in Q3 2022.
- MVM Partners (UK) opened 0 new positions and closed 2 in Q3 2022.
- MVM Partners (UK)'s portfolio value fell 47% quarter-over-quarter to $149M.
Based on MVM Partners (UK)'s 13F filing for Q3 2022, filed 25 Oct 2024.